SCHEMBL3359397

SCHEMBL3359397

Cc1cc(=O)oc2c(C)c3oc(CBr)c(C)c3cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.53
ALDH1A1 P00352 6/20 0.53
MAPK1 P28482 3/20 0.53
MAOA P21397 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP1A2 P05177 1/20 0.53
HTR2C P28335 1/20 0.53
ADORA2A P29274 1/20 0.53
MAOB P27338 2/20 0.52
L3MBTL1 Q9Y468 5/20 0.46
LMNA P02545 5/20 0.46
MAPT P10636 3/20 0.46
HPGD P15428 3/20 0.46
HTT P42858 3/20 0.46
KCNA3 P22001 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HSD17B10 Q99714 3/20 0.46
UBE2N P61088 1/20 0.46
TSHR P16473 2/20 0.45
GAA P10253 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9132405 0.88 KDM4E (0.50) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL4187785 0.88 KDM4E (0.50) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL5489202 0.84 KDM4E (0.53) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL4187788 0.84 KDM4E (0.53) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL498438 0.84 KDM4E (0.53) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL4182898 0.84 KDM4E (0.53) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL3363862 0.80 KDM4E (0.51) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL9133522 0.79 KDM4E (0.50) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL4194826 0.78 ALDH1A1 (0.60) KDM4EALDH1A1MAPK1MAOACYP3A4
SCHEMBL6996035 0.77 MCL1 (0.45) KDM4EALDH1A1MAPK1MAOACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1508345-B1 System and method for the reduction of small organic compounds from blood products CERUS CORP (US) 2013-09-25 EP claimed
US-20060093999-A1 For reducing the concentration of low molecular weight compounds in a biological composition containing cells while substantially maintaining a desired biological activity; comprises highly porous adsorbent particles CERUS CORPORATION 2006-05-04 US claimed
US-7037642-B2 Removing compounds from blood products with porous particles immobilized in a matrix CERUS CORPORATION (US) 2006-05-02 US claimed
US-6951713-B2 Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix CERUS CORPORATION (US) 2005-10-04 US claimed
US-20050142542-A1 ABSORBING PATHOGEN-INACTIVATING COMPOUNDS WITH POROUS PARTICLES IMMOBILIZED IN A MATRIX CERUS CORPORATION 2005-06-30 US claimed
EP-1508345-A1 Absorbents and devices for the reduction of small organic compounds from blood products Cerus Corporation (US) 2005-02-23 EP claimed
EP-0954374-B1 ADSORBENS AND DEVICES FOR THE REDUCTION OF SMALL ORGANIC COMPOUNDS FROM BLOOD PRODUCTS CERUS CORP (US) 2004-11-24 EP claimed
US-20160354533-A1 ADSORBING PATHOGEN-INACTIVATING COMPOUNDS WITH POROUS PARTICLES IMMOBILIZED IN A MATRIX CERUS CORPORATION (US) 2016-12-08 US disclosed
US-9259525-B2 Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix CERUS CORPORATION (US) 2016-02-16 US disclosed
EP-1508345-B1 System and method for the reduction of small organic compounds from blood products CERUS CORP (US) 2013-09-25 EP disclosed
US-20100133160-A1 ADSORBING PATHOGEN-INACTIVATING COMPOUNDS WITH POROUS PARTICLES IMMOBILIZED IN A MATRIX CERUS CORPORATION 2010-06-03 US disclosed
EP-0840781-B1 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS CERUS CORP (US) 2009-12-09 EP disclosed
EP-1584622-B1 Compounds for the photodecontamination of pathogens in blood CERUS CORP (US) 2009-11-11 EP disclosed
US-5585503-A PSORALEN COMPOUNDS STERITECH, INC. (US) 1996-12-17 US disclosed
US-5578736-A SUBSTITUTED PSORALENS STERITECH, INC. (US) 1996-11-26 US disclosed
US-5556993-A PSORALEN COMPOUNDS FOR DEACTIVATION OF HEPATITIS AND HIVVIRUSES STERITECH, INC. (US) 1996-09-17 US disclosed
WO-1996014739-A1 COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD CERUS CORPORATION (US) 1996-05-23 WO disclosed
EP-0707476-A1 COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD STERITECH, INC (US) 1996-04-24 EP disclosed
US-5399719-A 4'-/4-Amino-2-oxa/butyl-4,5',8-trimethylpsoralen; preparation of 4'-/omega-amino-2-oxa/alkyl-4,5',8-trimethylpsoralens by reacting analogous omega-hydroxy compound with methanesulfonyl chloride and base, with sodium azide, with reducing agent STERITECH, INC. (US) 1995-03-21 US disclosed
WO-1995000141-A1 COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD STERITECH, INC. (US) 1995-01-05 WO disclosed